Final Results of the Phase I Study of Lenalidomide In Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL-001 Study) 52nd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) Wendtner, C., Hillmen, P., Mahadevan, D., Stilgenbauer, S., Uharek, L., Coutre, S., Frankfurt, O., Bloor, A., Bosch, F., Furman, R. R., Kimby, E., Gribben, J. G., Gobbi, M., Dreisbach, L., Hurd, D. D., Sekeres, M. A., Ferrajoli, A., Shah, S., Zhang, J., de Parseval, L. M., Chanan-Khan, A. A. AMER SOC HEMATOLOGY. 2010: 591–92

View details for Web of Science ID 000289662201479